CBD Oil Headlines https://cbdoilheadlines.com Sun, 31 May 2020 11:58:29 +0000 en-US hourly 1 https://wordpress.org/?v=5.3.3 MDMA-Assisted Therapy For PTSD Likely To Get FDA Approval By 2022 – Benzinga https://cbdoilheadlines.com/mdma-assisted-therapy-for-ptsd-likely-to-get-fda-approval-by-2022-benzinga/?utm_source=rss&utm_medium=rss&utm_campaign=mdma-assisted-therapy-for-ptsd-likely-to-get-fda-approval-by-2022-benzinga Sun, 31 May 2020 11:58:29 +0000 http://CBMiemh0dHBzOi8vd3d3LmJlbnppbmdhLmNvbS9tYXJrZXRzL2Nhbm5hYmlzLzIwLzA1LzE2MDk2MzM5L21kbWEtYXNzaXN0ZWQtdGhlcmFweS1mb3ItcHRzZC1saWtlbHktdG8tZ2V0LWZkYS1hcHByb3ZhbC1ieS0yMDIy0gEA By The Fresh Toast‘s Brendan Bures, provided exclusively to Benzinga Cannabis. MDMA-assisted psychotherapy is expected to receive FDA approval by 2022, following successful Phase 3 trials. The Food and Drug Administration (FDA) tapped MDMA as a “breakthrough therapy” to treat post-traumatic stress disorder three years ago. This was seen as monumental because, […]

The post MDMA-Assisted Therapy For PTSD Likely To Get FDA Approval By 2022 – Benzinga appeared first on CBD Oil Headlines.

]]>

By The Fresh Toast‘s Brendan Bures, provided exclusively to Benzinga Cannabis.

MDMA-assisted psychotherapy is expected to receive FDA approval by 2022, following successful Phase 3 trials.

The Food and Drug Administration (FDA) tapped MDMA as a “breakthrough therapy” to treat post-traumatic stress disorder three years ago. This was seen as monumental because, like cannabis, MDMA is classified as a Schedule I drug by the Drug Enforcement Agency (DEA). That designation is given to drugs “with no currently accepted medical use and a high potential for abuse.”

Fast forward to the present day and the Multidisciplinary Association for Psychedelic Studies (MAPS), the organization behind the MDMA research, is experiencing rapid success with their Phase 3 clinical trials examining how MDMA can treat PTSD. According to MAPS founder Rick Doblin, the FDA is set to approve MDMA-assisted therapy for PTSD by 2022. The organization believes such treatment will become widely available the following year.

To be clear, this research doesn’t mean dropping MDMA acts as a cure-all for PTSD. Instead, this treatment combines MDMA with traditional psychotherapy where trained professionals guide patients to therapeutic outcomes. In Phase 2 trials, in which researchers test the efficacy of a new treatment, MAPS-sponsored studies found that more than half of patients no longer experienced PTSD symptoms after two months. At the 12-month mark, the figure was even higher—two-thirds of patients who received MDMA-assisted psychotherapy didn’t meet the diagnostic criteria for PTSD.

RELATED: The Main Dos And Don’ts When First Using CBD

Doblin’s optimism comes following a recent interim analysis conducted amid Phase 3 trials, which are scientifically rigorous as approximately 25-30% of experimental treatments receive approval. In agreement with the FDA, third-party data monitoring committees (DMC) typically review Phase 3 clinical trials after 60% of participants have completed the study. After analyzing the MAPS trials, the DMC determined a 90% probability the study will produce statistically significant data once all participants have finished.

The Connection Between Cannabis And Multiple Sclerosis

Photo by rawpixel.com

In other words, the treatment should meet FDA approval.

“In the pharmaceutical drug development community, this is what you dream about,” Doblin told Forbes. “The results of the interim analysis of MAPS’ pivotal first Phase 3 trial are the most powerful evidence yet that MDMA-assisted psychotherapy could help transform the lives of people suffering from PTSD.”

RELATED: Epilepsy And Cannabis: The Latest Research

MAPS have already begun preparing next steps following the research’s conclusion. The organization launched a $30 million Capstone fund, with already $12 million raised, attracting big names like Dr. Bronner CEO David Bronner and Austin Hearst, the grandson of William Randolph Hearst. MAPS will partner with the Psychedelic Science Funders Collaborative (PSFC) to raise additional funding.

“This first look at data from the first-ever Phase 3 trial of a psychedelic-assisted therapy only makes us more confident that we’re standing on the cusp of a breakthrough,” PSFC co-founder Joe Green told Forbes. “The approval of MDMA-assisted psychotherapy would be a catalytic event that brings psychedelic medicine into the mainstream.”

photo by Pornpak Khunatorn/Getty Images

Noticias sobre psicodélicos en Español en El Planteo.

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Source: https://www.benzinga.com/markets/cannabis/20/05/16096339/mdma-assisted-therapy-for-ptsd-likely-to-get-fda-approval-by-2022

The post MDMA-Assisted Therapy For PTSD Likely To Get FDA Approval By 2022 – Benzinga appeared first on CBD Oil Headlines.

]]>
Free Veterinary Care Provided to LA Pets in Need – Spectrum News 1 https://cbdoilheadlines.com/free-veterinary-care-provided-to-la-pets-in-need-spectrum-news-1/?utm_source=rss&utm_medium=rss&utm_campaign=free-veterinary-care-provided-to-la-pets-in-need-spectrum-news-1 Sun, 31 May 2020 06:08:32 +0000 http://CBMicmh0dHBzOi8vc3BlY3RydW1uZXdzMS5jb20vY2EvbGEtd2VzdC9pbnNpZGUtdGhlLWlzc3Vlcy8yMDIwLzA1LzMwL2ZyZWUtdmV0ZXJpbmFyeS1jYXJlLXByb3ZpZGVkLXRvLWxhLXBldHMtaW4tbmVlZNIBAA LOS ANGELES – Amanda Howland and her team at ElleVet are on a mission to help as many people and pets as possible. What You Need To Know ElleVet is offering free veterinary care The efforts are part of a two-month tour Stopping in some of the most underserved communities ElleVan […]

The post Free Veterinary Care Provided to LA Pets in Need – Spectrum News 1 appeared first on CBD Oil Headlines.

]]>

LOS ANGELES – Amanda Howland and her team at ElleVet are on a mission to help as many people and pets as possible.


What You Need To Know

  • ElleVet is offering free veterinary care
  • The efforts are part of a two-month tour
  • Stopping in some of the most underserved communities
  • ElleVan filled with all the supplies and materials they need

“We had a line since we got here this morning,” said Howland, who co-founded the company.

ElleVet is offering free veterinary care and services to those on Skid Row who need it most.  

“People who are experiencing homelessness either due to COVID or who were already in that situation, have even less resources and that trickles down to the pets,” Howland said.

The efforts are part of a two-month tour from San Diego to San Francisco, stopping in some of the most underserved communities.

“People said, ‘Oh you couldn’t possibly pull off a project like that in a month,’ and we said, well, this is when people need us,” Howland said.

“I’ve had him two and a half months,” said Rick Smith, who showed up with his dog, Milo. “He’s a good dog, real good dog. He was due his boosters last month, and the clinic was shut down, so I heard they were out here, so that’s what I did.”

Smith says they de-wormed him and gave him some stuff for pain, fleas, and ticks as well as some treats. But it wasn’t just dogs. One woman even showed up with a box of cats.

Howland showed off the ElleVan, which is the motorcoach that has become her team’s home away from home during this campaign.

“We had to learn to drive it and also learn about living in an RV,” she said.

It is filled with all the supplies and materials they need, including ElleVet’s own pet products that contain CBD.

“They have joint pain or stiffness and we help with that, but also stress is a huge problem with a lot of dogs, separation issues, maybe noise,” Howland said.

If the team can’t help, they will refer pets to a low cost or free clinic that might be available.  Howland says while doing this kind of work, she’s truly seen the strength of the human-animal bond.

“It doesn’t matter who you are, how much you have for resources, $5 or $5 million, it doesn’t make any difference,” Howland said. “Everyone loves their pets.”

ElleVet will be in town through Friday, May 29. To find out their location, check out their Facebook, Instagram, or call (844) 695-4596.

Source: https://spectrumnews1.com/ca/la-west/inside-the-issues/2020/05/30/free-veterinary-care-provided-to-la-pets-in-need

The post Free Veterinary Care Provided to LA Pets in Need – Spectrum News 1 appeared first on CBD Oil Headlines.

]]>
Where to buy CBD in Bethesda https://cbdoilheadlines.com/where-to-buy-cbd-in-bethesda/?utm_source=rss&utm_medium=rss&utm_campaign=where-to-buy-cbd-in-bethesda Sun, 31 May 2020 06:08:24 +0000 https://healthworxcbd.com/?p=85092 Most people who are new to CBD and other cannabis-related products have wondered where to buy CBD in Bethesda. The question of where to buy CBD in Bethesda has been answered and its location has been pinpointed. Finding a place that offers good prices for CBD products is not an […]

The post Where to buy CBD in Bethesda appeared first on CBD Oil Headlines.

]]>
Most people who are new to CBD and other cannabis-related products have wondered where to buy CBD in Bethesda. The question of where to buy CBD in Bethesda has been answered and its location has been pinpointed. Finding a place that offers good prices for CBD products is not an easy task. Here are some tips to help you get started.

Click here to read about CBD Topicals!

There are many vendors who offer high-quality products at very low prices in today’s market. They offer great products and cheap prices due to a lack of competition. Vendors of CBD in Bethesda usually stock products that are not yet on the market. These products come from a small group of manufacturers who started the process of manufacturing CBD products. They are also making profits off of their products. Some vendors sell do-it-yourself kits, which allow a person to do the whole process. In order to make profits off of their product, the manufacturers must resell it. Vendors do not need to worry about losing money on the stock because the vendors themselves sell the products. This way, the vendors can make more money and don’t need to pay the manufacturers for their product.

CBD Fruit Chew Gummies for $59.99!

The websites of some local merchants include information about their products and prices. If you search the internet and open Google, you will find that there are millions of different websites where to buy CBD in Bethesda. In order to make the right choice when buying CBD products, you have to compare the products that are offered. The websites should be easy to navigate and contain pictures of the products as well as helpful information. Most websites offer a member’s forum where you can discuss the products with other users.

Where to buy CBD in Bethesda

Cannabidiol in Bethesda has become a hot topic recently. People have discovered that many individuals suffering from various medical conditions have found relief by using the product. People suffering from chronic pain, nausea, anxiety, cancer, and more have found relief by using the CBD in Bethesda product. The product is usually taken orally and delivers many benefits for those who use it. Make sure that the price range that you are willing to pay is affordable for you. Vendors should be able to give you a quote without compromising the quality of the product. Price should not be a factor if you want to make a decision regarding where to buy CBD in Bethesda.

Here are some places where you can buy CBD in Bethesda!

While you can buy it in these walk-in stores/institutions and pay a higher price, why not just buy it directly from us? We are a Colorado-based CBD Oil company, and all of our products are third-party lab tested for purity, potency, heavy metals, and pesticides. Click here to shop nowFurthermore, we hope we have answered your question in regards to Where to buy CBD in Bethesda!

Before making your purchase, make sure that you know the right time to buy CBD in Bethesda. Many vendors sell products that are made to order. They can give you a customized quote based on the quantity that you order. With this in mind, you can now choose a vendor who sells a wide variety of products and who will give you a discounted price for bulk orders. Looking for the best place to buy CBD in Bethesda can take a lot of your time. However, finding a vendor who can give you a discount and has a large selection of products is easier than you think.

Source: https://healthworxcbd.com/cbdstore-bethesda/

The post Where to buy CBD in Bethesda appeared first on CBD Oil Headlines.

]]>
Ways on How CBD is Changing the Health Industry – Plants Before Pills https://cbdoilheadlines.com/ways-on-how-cbd-is-changing-the-health-industry-plants-before-pills/?utm_source=rss&utm_medium=rss&utm_campaign=ways-on-how-cbd-is-changing-the-health-industry-plants-before-pills Sun, 31 May 2020 04:49:12 +0000 http://CBMiTWh0dHBzOi8vcGxhbnRzYmVmb3JlcGlsbHMuY29tLzUtd2F5cy1ob3ctY2JkLWlzLWNoYW5naW5nLXRoZS1oZWFsdGgtaW5kdXN0cnkv0gEA The terms cannabis and marijuana are often used interchangeably. However, the two words do not denote the same thing. Cannabis refers to a group of plants that are hailed for their immense medicinal properties. The three main variants of the cannabis plant include cannabis sativa, cannabis indica, and cannabis ruderalis. […]

The post Ways on How CBD is Changing the Health Industry – Plants Before Pills appeared first on CBD Oil Headlines.

]]>
The terms cannabis and marijuana are often used interchangeably. However, the two words do not denote the same thing. Cannabis refers to a group of plants that are hailed for their immense medicinal properties.

The three main variants of the cannabis plant include cannabis sativa, cannabis indica, and cannabis ruderalis. Marijuana is just one of the many variants of the cannabis plant, and is what often comes to mind when we think about the psychotropic properties of the plant. People use different variants of it including tinctures, gummies, or smokables like cheap weed and you’ll get this resource on australian seed banks.

From time immemorial, cannabis has been prescribed for a wide range of medical conditions, especially disorders that manifest in neuropathic and nociceptive pain. Research also indicates that cannabis can be used to relieve anxiety, and that shall be the focus of this post.

Description: A close up of the marijuana farm industry. Beautiful macro and micro shots. Green house, outdoor, indoor plants. Harvesting cannabis, planting weed and more.

Image Source: Adobe Stock

Anxiety refers to a sense of intense worry. Though it’s largely a mental condition, the symptoms of anxiety usually manifest in the physical body. Some of the signs include a racing heart, irritability, and mood swings. Anxiety may also result in gastrointestinal complications, such as nausea, vomiting, and diarrhea.

Like pain, anxiety could either be a one-off experience or the result of a chronic disorder. Examples of chronic anxiety disorders include post-traumatic stress disorder, panic disorder, and obsessive-compulsive disorder.

Conventional anxiety medications usually present two major problems. First, most of these drugs come with side effects. Secondly, and as is the case with most conventional medications, there are risks of tolerance and dependency. All of these effects prolong the recovery process, making the drugs ineffective in the long run.

Now, experts tout cannabis as the all-natural, high-effective alternative remedy for anxiety drugs. Cannabis comprises over 130 compounds, also known as cannabinoids. However, the two most widely studied compounds in cannabis include cannabidiol (CBD) and 9-delta tetrahydrocannabinol (THC). Both CBD and THC play a significant role in relieving anxiety.

Description: Concerned student lamenting outdoors

Image Source: Adobe Stock

The body is made up of a system of endogenous cannabinoids known as the Endocannabinoid System (ECS). The ECS is responsible for restoring normal body homeostasis. Some of its functions include pain relief, anxiety relief, treatment of inflammation, and regulating sleep, to mention but a few.

When you’re anxious, your body’s neurotransmitters register stress on your brain as an abnormality. And since the role of the ECS is to restore normal body homeostasis, the system sends your endocannabinoids to the sites that are mostly hit by anxiety. However, the ECS may not always be efficient at relieving anxiety, especially when it comes to chronic anxiety disorders whose symptoms are usually a bit more severe. That’s where CBD comes in.

When you consume a CBD product, the cannabinoids in the substance (known as phytocannabinoids) interact positively with your body’s endocannabinoid receptors (mostly CB1 and CB2 receptors) to enhance the efficiency of your endocannabinoid system. The effect is faster relief from anxiety. How fast it takes for CBD to relieve stress depends on the delivery method, as well as the lifestyle of the user. To find your body’s ideal CBD product, you can simply visit your doctor and make sure you start off slow and gradually build up potency with time. People get their dose of CBD covered by many cannabis products.

Another way CBD relieves anxiety is by interacting with serotonin. Serotonin is a neurotransmitter located in the brain which is associated with feel-good emotions, such as happiness and positivity. Low levels of serotonin in the body trigger feelings of sadness and despondency, which are common risk factors for stress and anxiety. A 2015 review supports the use of CBD as a potent anti-anxiety remedy.

On the other hand, THC treats anxiety by interacting with anandamide, which is a chemical present in our brains that’s associated with stress and anxiety. Anandamide and THC are structurally similar. So, when you consume a THC-containing product, THC easily recognizes anandamide and binds to it, thereby suppressing its stress-inducing abilities.

Besides suppressing the effects of anandamide, THC also interacts with CB1 receptors, most of which are located in the brain. The result of these interactions is an altered state of mind, also known as euphoria. The euphoric effects of THC help to relieve anxiety in various ways. Most notably, it makes you banish your worries and focus on the things that make you happy. So, if the prospect of a job interview or public presentation is causing butterflies in your stomach, a dose of THC might help you to focus on the bright side. 

There are tons of studies backing the potency of THC for stress and anxiety relief, and most of them borrow from the psychotropic properties of the substance.

Yes, you can. As a matter of fact, experts recommend using these two products synergistically to deliver the famous Entourage Effect. That also means watching your doses closely.

In terms of dosing, CBD works better with high doses, while THC tincture canada delivers optimal anxiety-relief effects at low doses. Typically, CBD has no potential for overdosing as it has no psychotropic or intoxicating effects. However, the general rule for either substance is to start small and work your way up.

Description: panoramic shot of doctor in white coat holding cbd isolated on white

Image Source: Adobe Stock

Cannabis can fight anxiety. Both of the plant’s two most active extracts, CBD and THC, contain anti-anxiety properties. And using them together helps deliver compounded benefits.

Source: https://plantsbeforepills.com/5-ways-how-cbd-is-changing-the-health-industry/

The post Ways on How CBD is Changing the Health Industry – Plants Before Pills appeared first on CBD Oil Headlines.

]]>
‘There Is An Active Discussion Of CBD Happening Across The Country,’ Says A New Report. And That Spells Opportunity. – Forbes https://cbdoilheadlines.com/there-is-an-active-discussion-of-cbd-happening-across-the-country-says-a-new-report-and-that-spells-opportunity-forbes/?utm_source=rss&utm_medium=rss&utm_campaign=there-is-an-active-discussion-of-cbd-happening-across-the-country-says-a-new-report-and-that-spells-opportunity-forbes Sun, 31 May 2020 04:48:44 +0000 http://CAIiEDLoTAx3pFlt4P0yLhzgGVoqFQgEKg0IACoGCAowrqkBMKBFMMGBAg Americans report positive associations with CBD in a new report from New Frontier Data. Getty Images In 2017, when celebrity host (The View) Whoopi Goldberg was enjoying the high point of her then-new CBD brand, Maya & Whoopi, a reporter asked what the next step was. “World domination,” Goldberg joked […]

The post ‘There Is An Active Discussion Of CBD Happening Across The Country,’ Says A New Report. And That Spells Opportunity. – Forbes appeared first on CBD Oil Headlines.

]]>
Some 48% of Americans surveyed reported positive feelings to researchers about CBD and 61% believed it has valid medical uses.

Americans report positive associations with CBD in a new report from New Frontier Data.

Getty Images

In 2017, when celebrity host (The View) Whoopi Goldberg was enjoying the high point of her then-new CBD brand, Maya & Whoopi, a reporter asked what the next step was. “World domination,” Goldberg joked at the time.

She might have been onto something.

Goldberg this year parted ways with her business partner, Maya Elisabeth; the result was that their company folded. But if Goldberg back in 2017 was predicting a big future for CBD startups, she wasn’t off the mark, judging from a the findings of a new survey from New Frontier Data.

“The newness of the CBD experience for most consumers suggests there remains significant opportunity for well-developed brands to attract consumer attention and capture market share from existing market leaders,” the report says. A big reason why startups might have an edge, the researchers imply? The novelty factor.

“Consumers have not been using the products with sufficient longevity to create durable brand loyalty that is difficult to dislodge,” the report says.

To compile the study, New Frontier Data surveyed 4,074 U.S. adults in mid-March. The survey population consisted of 26% of subjects who earned less than $30,000; 27% earning $39,000 to $59,999; 27% earning $60,000 to $89,999; and 16% earning $90,000 and up.

Among the report’s chief takeaways:

Familiarity with CBD is an important factor

·     CBD is hardly unknown to the American mainstream. “Nearly 9 in 10 Americans are familiar with CBD,” the report says. Some 86% of those surveyed had heard of CBD, and a majority (55%) were interested in learning more. Younger cohorts tended to be more interested than older groups.

·     Word of mouth is a common thread: Nearly 3 in 4 (73%) of those surveyed who’d heard of CBD reported having had a conversation about it, including the 67% who had not consumed it. People reported that their conversations were largely positive.

·     Positive associations: 51% of those surveyed knew a friend or family member who’d used CBD, and nearly 1 in 5 (17%) had recommended CBD to someone else.

·     Frequency: Among Americans who reported ever having consumed CBD, 40% said they did so at least once a week, with older consumers using it more frequently than younger ones.

·     CBD consumers seem to be evangelists. A majority, 56%, said they had recommended CBD products to someone else.

Stress and pain are major reasons for use

·     Three in five (60%) of consumers surveyed reported using CBD in a context that might be called “unwinding,” such as relaxation, relief of stress or anxiety reduction. The primary use, however (41%), was pain management.

Means of  Consumption

·     Oils and tinctures led the way, at 38% (of the ways in which consumers surveyed consume CBDs). Topicals were the next most widely used method, at 19%; then: food or drinks, 18%; flower, 8%; pills/capsules, 7%; and vaping, 7%.

·     Some 43% of consumers said they used less than 30 mg. a day; 22% reported using 50 mg. or more; and 12% used 100 mg. or more a day.

·     Some 65% of consumers surveyed said CBD had positively affected their quality of life. Only 2% described a negative effect.

Level of expenditure

·     Most consumers (59%) said they spent less than $50 a month on CBD.

Gender Differences

·     Some 46% of male consumers surveyed said they used CBD at least once a week, versus 36% of women in the survey population.

·     On average, men spent more for CBD than did women. Men were more likely (21%) than women (12%) to spend more than $100 per month. Purchasers ages 35 to 54 were the most likely (21%) of any group to spend more than $100 per month.

Decision Factors

·     CBD purchasers reported being generally happy with the products they were able to purchase, depending on the regulations in their geographic area; 71% agreed they were satisfied with their purchases.

·     When selecting which CBD product to purchase, price and quantity of CBD were the most important factors to those surveyed. Convenience of location and service from staff were also important criteria.

·     Some 51% of purchasers said they usually purchased familiar brands. About 29% said they would be likely to purchase CBD in the next six months.

Where the Opportunities Lie

For CBD startups, the women’s market for might be one smart place to focus, considering that male survey respondents were far more likely (21%) than women (12%) to spend more than $100 per month.

Another wise move might be to market only products backed by clinical studies and clear, authoritative information. The reasons here would be the importance consumers put on reliable information, as well as the strict FDA restrictions against promoting CBD for medical purposes.

Infusions as a method for consumption also seem to be of growing interest, while smoking is losing users due to social norms, especially during the current COVID-19 crisis when so many cannabis medical users are housebound.

Finally, given the anxiety during the crisis and the prevalence of word of mouth in spreading information about CBDs, companies might want to turn to such marketing channels as referral discounts, loyalty programs and high-production-value consumer testimonials, according to the New Frontier Data report.

Source: https://www.forbes.com/sites/joanoleck/2020/05/28/there-is-an-active-discussion-of-cbd-happening-across-the-country-says-a-new-report-and-that-spells-opportunity/

The post ‘There Is An Active Discussion Of CBD Happening Across The Country,’ Says A New Report. And That Spells Opportunity. – Forbes appeared first on CBD Oil Headlines.

]]>
Colorado CBD Product Manufacturers May Sell Into State-Licensed Cannabis Dispensaries – Hemp Grower https://cbdoilheadlines.com/colorado-cbd-product-manufacturers-may-sell-into-state-licensed-cannabis-dispensaries-hemp-grower/?utm_source=rss&utm_medium=rss&utm_campaign=colorado-cbd-product-manufacturers-may-sell-into-state-licensed-cannabis-dispensaries-hemp-grower Sun, 31 May 2020 04:48:39 +0000 http://CBMiUmh0dHBzOi8vd3d3LmhlbXBncm93ZXIuY29tL2NvbG9yYWRvLWNiZC1pbmR1c3RyaWFsLWhlbXAtY2FubmFiaXMtZGlzcGVuc2FyaWVzLmFzcHjSAQA The “Hemp for Our Future” campaign is a new social responsibility effort that shines a spotlight on the possibilities of the hemp crop at a particularly fraught juncture in the industry. Not only is hemp a relatively new legal crop for American farmers, but the ongoing coronavirus pandemic has quickly […]

The post Colorado CBD Product Manufacturers May Sell Into State-Licensed Cannabis Dispensaries – Hemp Grower appeared first on CBD Oil Headlines.

]]>

The “Hemp for Our Future” campaign is a new social responsibility effort that shines a spotlight on the possibilities of the hemp crop at a particularly fraught juncture in the industry. Not only is hemp a relatively new legal crop for American farmers, but the ongoing coronavirus pandemic has quickly changed how industries work to support one another.

Hemp farmers around the U.S. will join forces with industry groups and other private businesses to produce and donate certain goods and materials for frontline health care workers. These may include food, clothing, hand sanitizers (produced in newly converted processing facilities) and personal protective equipment.

 

“One in seven people in Kentucky were struggling with hunger before the COVID-19 pandemic hit, and now that number is even bigger,” said Chad Rosen, CEO of Kentucky-based Victory Hemp Foods, in a public statement. His company contributed hundreds of pounds of hemp hearts to local food banks. “As a superfood ingredient manufacturer, we are trying to do what we can with what we have to help the greatest number of people. We decided to start by donating hundreds of pounds of nutrient-dense hemp hearts to food banks in the communities where we live. We are also encouraging others to take similar action, because even small acts can have a big impact.”

The campaign echoes the “Hemp for Victory” film that the U.S. government produced and distributed during World War II. At the time, another critical moment of crisis for the country, American farmers were encouraged to grow hemp crops to support the war effort and develop fiber materials for the military. The Marihuana Tax Act of 1937, a prohibition on the crop, was briefly lifted for just this purpose.

“Hemp for Our Future is currently focused on helping health care workers and others on the frontline of the COVID-19 crisis, but the network we have created will be able to continue doing good well into the future,” said Hemp for Our Future co-founder Courtney Moran, of Agricultural Hemp Solutions, in a public statement. “It is a meaningful way in which we can unite and strengthen this new industry, while also illuminating the utility and sustainability of this amazing crop. Now that commercial hemp production is federally legal in the U.S., we can put it to use to meet our country’s industrial material needs, while also regenerating our soils and rural economies.”

The campaign was co-founded by Vicente Sederberg LLP, Agricultural Hemp Solutions and Friends of Hemp. Shawn Hauser, partner and chair of Vicente Sederberg’s Hemp & Cannabinoid Law Practice Group, said in an interview with Hemp Grower that the crop is positioned in 2020 as a helpful vehicle for real chance and impact in the U.S.

“Hemp is uniquely suited to  be utilized for thousands of product types, from textiles, to plastics, to super foods, topicals, building materials—the list goes on,” she said. “As we see front line workers in need of everything from food to durable clothing material, as we see masks becoming standard uniform for our country, and as we see businesses innovate utilizing shields and separation mechanisms to operate safely, hemp materials are a clear solution. Hemp, a natural plant fiber, is a non-toxic, durable, and often bio-degradable material that has a host of beneficial properties. Making materials out of hemp, rather than many alternatives, is good for our planet.”

“Hemp for Our Future” member organizations as of late May include:

  • Agricultural Hemp Solutions
  • Cannabis Doing Good
  • Colorado Hemp Company 
  • Colorado Hemp Industries Association
  • EARTH Law LLC
  • Friends of Hemp
  • Hemp History Week
  • Hemp Industries Association
  • Hemp Road Trip
  • National Cannabis Industry Association
  • National Hemp Association
  • OP Innovates
  • Oregon Industrial Hemp Farmers Association
  • Oregon State University Global Hemp Innovation Center
  • Texas Hemp Educational Organization
  • U.S. Hemp Building Association
  • U.S. Hemp Growers Conferences & Expo
  • Vicente Sederberg LLP
  • Virginia Industrial Hemp Coalition
  • Vote Hemp

“Growers can connect with others who are involved in their communities to ensure supply for the materials that could be helpful to their community,” Hauser said. “Through the Hemp for Our Future website, companies will be able to connect with others involved in their community.”

Source: https://www.hempgrower.com/colorado-cbd-industrial-hemp-cannabis-dispensaries.aspx

The post Colorado CBD Product Manufacturers May Sell Into State-Licensed Cannabis Dispensaries – Hemp Grower appeared first on CBD Oil Headlines.

]]>
Business Briefs – Business – Times Record https://cbdoilheadlines.com/business-briefs-business-times-record/?utm_source=rss&utm_medium=rss&utm_campaign=business-briefs-business-times-record Sun, 31 May 2020 04:48:23 +0000 http://CBMiOWh0dHBzOi8vd3d3LnN3dGltZXMuY29tL2J1c2luZXNzLzIwMjAwNTMwL2J1c2luZXNzLWJyaWVmc9IBAA Chapters celebrates 4th year in bizz On Thursday, May 21, Chapters on Main in Van Buren celebrated its fourth birthday. Four years ago, Debbie Foliart became one of the original members of Van Buren Original. One of the goals of this group was to attract young people to downtown Van […]

The post Business Briefs – Business – Times Record appeared first on CBD Oil Headlines.

]]>

Chapters celebrates 4th year in bizz

On Thursday, May 21, Chapters on Main in Van Buren celebrated its fourth birthday.

Four years ago, Debbie Foliart became one of the original members of Van Buren Original. One of the goals of this group was to attract young people to downtown Van Buren. Foliart had the idea to purchase an old bookstore that had been sitting downtown without any care.

“We purchased the 25 year old bookstore in January 2016 and closed it to remodel the entire store,” Foliart said told the Press Argus-Courier.

National Roof Maxx opens Fort Smith store

Roof Maxx recently announced it is opening one of its newest locations in the River Valley. Roof Maxx claims to be “the world’s first all-natural roof maintenance spray treatment.”

The two new locations are part of a nationwide network of locally-owned dealers. Roof Maxx says they offer “a quick, easy and affordable solution to a potentially complicated, expensive and life-disrupting roof replacement.”

“We are so excited to bring this innovative, unique product to the River Valley and Northwest Arkansas,” said Aaron McGrew and Lance Smythe, Roof Maxx Certified Dealers. “Roof Maxx is dedicated to keeping money in our customers’ pockets and shingles out of the landfill, both of which we know are important to Arkansans. We are looking forward to educating our area about this new roofing solution.”

Roof Maxx’s technology allows millions of micro-beads of all-natural oil to penetrate an old brittle roof, restoring a roof’s flexibility and waterproofing protection, preserving the life of a roof.

86% of Americans know of CBD

New Frontier Data in partnership with payments innovator Square released this week the first volume of its newest CBD series, U.S. CBD Consumer Report: Archetypes and Preferences. Based on the largest U.S. CBD consumer survey to date, the report analyzes and outlines nine unique consumer and non-consumer archetypes.

“Our research shows that 1 in 5 Americans have used CBD, which demonstrates a major jump in consumer interest in the sector,” said New Frontier Data CEO Giadha Aguirre de Carcer. “While this phenomena is taking root across many other regions such as Europe and Latin America, the United States continues to represent the largest CBD market; understanding its CBD consumers is therefore a priority for enterprises within both the legal cannabis industry and a multitude of mature sectors such as Food & Beverage or Health & Beauty.”

Key findings from the report include:

CBD purchasers aged 35-54 are most likely (21%) of any group to spend over $100 per month on CBD.29% of Americans reported being likely to purchase CBD in the following six months.18% of Americans have tried CBD and 86% of Americans know of CBD.40% of CBD consumers report using CBD at least once a week.60% of American CBD consumers report using CBD for some form of unwinding (e.g., relaxation, relieving stress or anxiety reduction).The U.S. CBD Consumer Report: Archetypes and Preferences, Vol. 1 , executive summary is now available for free download on New Frontier Data’s website, and the full report via New Frontier Data’s cannabis business intelligence platform, Equio.

Source: https://www.swtimes.com/business/20200530/business-briefs

The post Business Briefs – Business – Times Record appeared first on CBD Oil Headlines.

]]>
Ethos Cannabis and Jefferson University Launch Their First Studies Under Pennsylvania’s Medical Cannabis Research Program – Cannabis Business Times https://cbdoilheadlines.com/ethos-cannabis-and-jefferson-university-launch-their-first-studies-under-pennsylvanias-medical-cannabis-research-program-cannabis-business-times/?utm_source=rss&utm_medium=rss&utm_campaign=ethos-cannabis-and-jefferson-university-launch-their-first-studies-under-pennsylvanias-medical-cannabis-research-program-cannabis-business-times Sun, 31 May 2020 02:58:19 +0000 http://CBMijAFodHRwczovL3d3dy5jYW5uYWJpc2J1c2luZXNzdGltZXMuY29tL2V0aG9zLWNhbm5hYmlzLWplZmZlcnNvbi11bml2ZXJzaXR5LWxhdW5jaC1zdHVkaWVzLXBlbm5zeWx2YW5pYS1tZWRpY2FsLWNhbm5hYmlzLXJlc2VhcmNoLXByb2dyYW0uYXNweNIBAA Ethos Cannabis and the Sidney Kimmel Medical College at Thomas Jefferson University have launched their first studies under Pennsylvania’s medical cannabis research program. Pennsylvania’s 2016 medical cannabis law allows medical cannabis operators to seek “clinical registrant” licenses to partner with one of the state’s medical schools, called “academic clinical research […]

The post Ethos Cannabis and Jefferson University Launch Their First Studies Under Pennsylvania’s Medical Cannabis Research Program – Cannabis Business Times appeared first on CBD Oil Headlines.

]]>

Ethos Cannabis and the Sidney Kimmel Medical College at Thomas Jefferson University have launched their first studies under Pennsylvania’s medical cannabis research program.

Pennsylvania’s 2016 medical cannabis law allows medical cannabis operators to seek “clinical registrant” licenses to partner with one of the state’s medical schools, called “academic clinical research centers,” to orchestrate patient-facing clinical studies into the benefits of medical cannabis.

RELATED: Pennsylvania Launches Medical Marijuana Research Program

“The medical schools cannot physically touch the plant, but they are interested in doing research,” Ethos President of Pennsylvania and CFO David Clapper told Cannabis Business Times. “They’re really interested in doing research, but to do it, they have to partner with a private group like us that can operate under state cannabis laws in the absence of federal regulation.”

Universities like Jefferson have historically had a difficult time conducting research on medical cannabis, not only for fear of losing their federal funding due to the plant’s Schedule-I status, but also because they lack access to patients and they are unable to identify exactly what the patients are taking.

“They’ve tried to do observational-type research over the years, but one of the biggest challenges is, ‘What exactly are the patients taking?’” Clapper said. “People don’t always remember to bring the medical marijuana bottle or vape labels with them to appointments with their physicians. Even if they know what they’re taking, they often don’t know exactly what is in medical marijuana that they’re using. … It’s been very difficult for Jefferson to do much in the way of real research, where they feel comfortable that they’re getting appropriate information.”

“We can do clinical research with patients that we can work with through their connection with Ethos and the Pennsylvania program,” added Dr. Brooke Worster, a physician in Jefferson University’s Sidney Kimmel Medical College. “It sidesteps that ever-challenging federal regulation whereby an academic medical center that gets federal funding would have to jump through all the hoops, with me having a Schedule I license … [and] getting product only from the University of Mississippi. … It gives us a little more flexibility … to understand what’s helpful, what’s tolerated [and] what adverse effects people are having, with a broad range of conditions and products.”

Under Pennsylvania’s research program, academic teaching hospitals had to apply for licenses first, demonstrating that they had identified a clinical registrant and had a research agreement in place.

“The way the program is set up is to require an ongoing research agreement with the hospital, in order to maintain your license,” Clapper said. “It’s a good program in that it keeps groups like us focused on the research.”

Ethos is one of seven clinical registrants currently licensed by the state to grow, process and dispense medical cannabis in partnership with an academic clinical research center, and the company is funding Jefferson’s research on the dispensary’s patients.

“I think Ethos has always had … an actual, real dedication to the research aspect of cannabis, not just doing it to get them the license,” Worster said. “They made a good partner because they really did have a lot of the same interests as we do, as far as, let’s get more data and more knowledge about this because it’s helpful for us, for our patients, for our caregivers [and] for disease management. … I think that’s what made them a good partner from the start.”

Roughly 300 of Ethos’ patients have enrolled in the first observational research study with Jefferson, which will track which products patients are taking, why they are taking them and specific dosage information. Patients are surveyed regularly for one calendar year to provide insight into how the products are affecting them and their medical condition.

“Just by studying the population here, we’ll start seeing trends that will help us distinguish the signal from the noise on, what is the low-hanging fruit?” Worster said. “What are the things where this seems to be very well tolerated and very helpful?”

Ethos and Jefferson are also considering future studies on opioid use.

“Jefferson has seen anecdotal information that suggests if you pair opiates with medical marijuana, you may be able to lower the amount of opiates used by patients and still get the same level of treatment for the condition,” Clapper said. “Jefferson would like to study patients that are using opiates for specific conditions, pair that with medical marijuana, and see what the results are compared to patients who are using only opiates to treat the condition.”

Another potential study would focus on how medical cannabis affects gastrointestinal cancer symptoms, he added.

“Jefferson is seeing what appears to be a positive correlation between people who are using medical marijuana and their ability to withstand chemo treatments for a longer period of time, and that’s something that can be game-changing for GI cancer,” Clapper said.  “What they’ve seen anecdotally is that people who are using medical marijuana to treat their cancer and chemo symptoms are able to maintain a better appetite and positive outlook which is necessary for withstanding extensive chemo treatments.”

The Ethos team will work closely with Jefferson to develop new product formulations that align with the university’s research goals.

“We are talking about doing different studies with a transdermal patch or a metered dose inhaler, products that are out there in some markets, but that haven’t gotten a lot of traction. These types of products may lead to alternative methods for using medical marijuana,” Clapper said. “We can use Jefferson’s research information to help create different products or the right delivery mechanism.”

Through Ethos’ participation in Pennsylvania’s research program, Clapper hopes that medical cannabis can eventually become an accepted part of healthcare.

“People are using medical marijuana to treat many different conditions and symptoms, and a majority of states have passed medical marijuana laws, but there are still a lot of doctors who don’t feel like it’s an appropriate part of healthcare,” he said. “How do you change that? … You start to change it when reputable medical schools like Jefferson perform research and publish the results.”

The research conducted through the program must be published, and every study must be approved through the Pennsylvania Department of Health, which provides a timeline for reporting.

“Marijuana’s not going away; more and more of our patients are turning to it, and we don’t have anywhere near the level of sophisticated data about it that we do lots of other pharmacotherapies,” Worster said. “So, it’s a very interesting, much-needed role that Jefferson’s research machine can play here. I don’t want to say it’s simple, but from our perspective, if we can find the means and the partnership and the interest to pursue needed research, then it’s kind of a no-brainer.”

Source: https://www.cannabisbusinesstimes.com/ethos-cannabis-jefferson-university-launch-studies-pennsylvania-medical-cannabis-research-program.aspx

The post Ethos Cannabis and Jefferson University Launch Their First Studies Under Pennsylvania’s Medical Cannabis Research Program – Cannabis Business Times appeared first on CBD Oil Headlines.

]]>
A Totally Non-Scientific Test of 6 Non-Approved Supplements – Gear Patrol https://cbdoilheadlines.com/a-totally-non-scientific-test-of-6-non-approved-supplements-gear-patrol/?utm_source=rss&utm_medium=rss&utm_campaign=a-totally-non-scientific-test-of-6-non-approved-supplements-gear-patrol Sun, 31 May 2020 02:48:22 +0000 http://CBMiPWh0dHBzOi8vZ2VhcnBhdHJvbC5jb20vMjAyMC8wNS8zMC9zdHJhbmdlLXN1cHBsZW1lbnRzLXRlc3RlZC_SAQA When you write about products for a living, trying stuff out is part of the job. Product testing isn’t an exact science, though. It might entail heating up and cracking eggs into seven different cast iron skillets to see if they flip or stick. Or it might mean flying across […]

The post A Totally Non-Scientific Test of 6 Non-Approved Supplements – Gear Patrol appeared first on CBD Oil Headlines.

]]>
When you write about products for a living, trying stuff out is part of the job. Product testing isn’t an exact science, though. It might entail heating up and cracking eggs into seven different cast iron skillets to see if they flip or stick. Or it might mean flying across the country to climb a volcano in clothing made by the guy on the other end of the rope that’s keeping you from plummeting into one of the crevasses that pierce its side.

A good product test derives from the product itself. It starts by taking the thing head-on; if Item A claims its primary reason for existence is to carry out Function Z, well, then Z is an excellent place to begin a test. That makes testing supplements an imprecise science.

Supplements — vitamins, tonics, CBD and more — are vague by legal definition in the United States. The Food and Drug Administration classifies and regulates them as food instead of drugs, which means that they aren’t subject to the rigorous testing and approval process that medication is. There probably isn’t much motivation to change that either, given that, according to the FDA, three out of four Americans use a supplement regularly, and the industry is worth $50 billion and counting.

“Increase energy,” “improve mental clarity,” “Support focus,” and “boost immunity” are a few top-line declarations you’ll find printed on the sides of jars of pills and tubs of powders. They take aim at the immeasurable abilities that are core to who we are and, in an era of constant visual and audio input, are constantly under assault. (Even if you want to take a break from it all by meditating, chances are you’re using an app to do that.) It’s no wonder that so many of us turn to supplements to make things better, if even just a little.

But if supplements don’t have to back up these generous and sweeping claims with a rigorous approval process, I don’t think my tests do either. So instead of finding a neuroscientist with the right background and equipment for measuring the effects of some of the substances I’ve recently been emailed about or sent via UPS, I decided to just pop ’em down the hatch and see how I felt. Call it the Eclectic Fuel-Aid Acid Test…

Beekeeper’s Naturals B.LXR Brain Fuel

What It Claims to Do

“Fight brain fog,” “support focus and mental energy,” “get productive,” “caffeine-free energy” and “support focus and brain health.”

What It Is

The working ingredients in B.LXR are royal jelly, bacopa monnieri plant extract and ginkgo biloba leaf extract. The latter two are plant extracts common in Ayurveda, the Hindu system of medicine that relies on diet, herbs and physical wellness to promote holistic health. But the former is the more interesting one; royal jelly is a substance that worker bees secrete from their heads. It is sometimes called “bee milk,” and it earns its prestigious moniker because queen bees consume it while workers do not. It’s mostly water but does contain proteins, sugars, fats and minerals in small amounts.

Verdict

Honey bee head spit? B.LXR, a dark liquid that comes in little 10-milliliter glass vials, is easily one of the weirdest supplements to cross my desk (powdered thousand-year-old plant matter is another). The directions say to start with a third or a half of a bottle, but to tip back the entire thing for “PEAK brain power,” so that’s what I did.

It does not, I repeat, does not taste like honey. But it is honey-like, starting sweet before bearing into an herbal bitterness that calls to mind diluted echinacea, which must be the plant extracts at work in this mix. It did seem to give me a small, immediate kick. Was it a placebo? A high I was riding, knowing that I consumed the elixir of the bee gods? As the afternoon progressed, my energy, already sapped from a poor night’s sleep, waned as it typically does. Perhaps I should order enough vials to bathe in this stuff, like a queen bee larva.

I like this stuff, but given its price, I won’t be stocking my cabinet with it.

Neuro Gum

What It Claims to Do

“Feel your best quickly and conveniently;” “focus your mind and provide mental endurance.”

What It Is

Neuro Gum’s active ingredients are caffeine, L-theanine, and vitamins B6 and B12. Unlike bee snot, we know caffeine’s effects on energy and focus, and one piece of gum has 40 milligrams of it — there’s roughly 95 in an eight-ounce cup of coffee. L-theanine is an amino acid found in tea leaves that’s believed to promote relaxation (Neuro Gum says it’s here to reduce the adverse effects of caffeine). Both B vitamins contribute to red blood cell and nervous system health.

Verdict

It tastes like mint gum! Go figure. There’s a hint of that chemical-sweet flavor, the type that’s common in energy products, layered beneath the peppermint. Is it good gum? Surprisingly — I approach any gum that isn’t Wrigley’s with skepticism that it’ll turn into a lump of flavorless, wet paper within 15 seconds of chewing — yes. It holds its spring nicely; it even maintains a sufficient shadow of its flavor during prolonged chewing.

Oh, and that whole “mental endurance” part? I couldn’t really tell if the gum had kicked in, so I popped another piece in (the box says to take one or two). It gave me a boost, but not in a jittery, third-cup-of-coffee sort of way. I don’t drink that much coffee, and I have a feeling that frequent drinkers might find Neuro Gum insufficient in afternoon resuscitation.

Would chew again.

Floyd’s of Leadville Recovery Protein

What It Claims to Do

“Optimum muscle replenishment,” “relax and recover” and “it’s also delicious.”

What It Is

Like many protein powder blends, the list of ingredients that make Floyd’s Recovery Protein is long, but the principal components are somewhat straightforward: 27 grams of whey protein, 25 milligrams of CBD and 10 grams of carbohydrates (plus organic cacao powder) per serving.

There are 18 amino acids present in the mix, including 8.5 grams of branched-chain amino acids (BCAAs), a type that the body doesn’t produce that has become somewhat trendy recently as some research has shown that they can reduce muscle fatigue and soreness and thereby aid in the overall recovery process.

Verdict

First thing’s first: it is delicious. Chocolate is likely the most common protein flavor, but this one ranks high on my list. And let’s be fair, flavor is important; if you have to gag down a post-workout drink, there’s probably a higher chance you pass it up entirely.

I’m a believer in post-workout recovery formulas. I’ve relied on them heavily in training for marathons, where an inadequate meal after a long run can leave you pilfering the fridge for 12 hours trying to satisfy cravings. In terms of fatigue, they can play a big role in ensuring the rest of the day doesn’t become a wash.

The first time I used Floyd’s Recovery Protein, it was after a failed attempt at a 12-mile trail run that would’ve involved roughly six miles of high ridge running, and the views that go with it. Because I didn’t expect the high forest to be filled with snow in mid-May, that turned into a seven-mile out-and-back slog.

I have no proof that this got me back on my feet quicker than if I didn’t consume it — it certainly did nothing for my scratched and bloody shins — but I went about the rest of my day regularly and tackled a different trail the following morning. The CBD? Didn’t notice it.

When I go back for redemption on that trail, I’ll make sure my bag of Floyd’s is waiting for me at the end.

Momentous Elite Sleep

What It Claims to Do

“Fall asleep easier and achieve higher quality sleep, thus improving recovery and performance.”

What It Is

Elite Sleep contains both magnesium and Magtein, a patented magnesium compound believed to support cognitive function and brain health, and reduce anxiety, among other things. It also has wild jujube seed extract; jujube is also known as a red date or Chinese date and supposedly does all kinds of things, from fortifying the immune system to supporting liver health. Momentous uses it for its purported ability to increase the time spent in slow-wave and rapid eye movement sleep phases.

Elite Sleep’s final ingredient, melatonin, is more straightforward. Melatonin is a hormone that the body produces on its own to manage your circadian rhythm.

Verdict

Yeah, this definitely, objectively works. Again, I can’t speak for the direct effects that popping one of these little pills before bed has on my brain function or muscle regeneration, but it did make me notably drowsy, and I do seem to be getting more restful sleep. Better sleep leading to better athletic and daily performance is a simple equation in my book. (Plus, it’s proven.)

On some mornings after taking Elite Sleep, I woke up a little drowsier than usual. I’m too nervous about messing with the winder on my body clock, but I’m happy to rely on this stash when I’m restless and have a big tomorrow ahead of me.

Charlotte’s Web CBD Sleep Gummies

What It Claims to Do

“Support sound, quality sleep, and regular sleeping cycles,” “help you get the rest you need when you need it,” “help you float off to dreamland.”

What It Is

Hemp extract and melatonin, plus the medium list of ingredients required to get those two things into a gummy form. The hemp extract is here to get cannabidiol, or CBD, which is easily this age’s most popular supplement. Yes, CBD is a supplement. The only FDA-approved CBD product is a prescription drug that treats two rare types of epilepsy. But the FDA does note that it can affect alertness in a way that causes drowsiness.

Verdict

I didn’t mention this in discussing Floyd’s Recovery Protein, but I’m a CBD skeptic. So many people, when they talk about CBD, either talk about it like it’s a minor form of THC (the compound in marijuana that gets you high) or that it’s a wonder-substance that can fix any problem you might have, be it anxiety or an inability to make a real connection with your mother-in-law.

I’m not discounting what people claim CBD does for them; if it helps, it helps (the placebo effect, after all, is proven). I’m just saying that I’m waiting for more conclusive studies — there are many of them underway — to play out before deciding what it might do for me.

One thing that experts seem to agree on is that CBD is safe to take, so I happily chowed down on Charlotte’s Web’s raspberry, hemp-enhanced gummies before tucking in for the night. They definitely made me feel relaxed and drowsy after 20 or so minutes, but was that the CBD or the three milligrams of melatonin (the same amount that’s in Momentous Elite Sleep)? Perhaps a better question is, does it matter, given that my reward for eating a tasty treat was a good night’s sleep?

Be careful: These taste good enough to commit to an entire day of gummy-induced napping.

Milkweed Truffletruffle White

What It Claims to Do

Nothing beyond providing the mellowed-out sugary bliss you’d expect from a pastry chef who earned his stripes in New York City before leaving that behind to work in medical marijuana and consequently connecting those two dots. Oh, and “whimsical delights.”

What It Is

“A sweet white chocolate shell filled with savory butterscotch, honey granules, and white truffle oil,” plus 40 milligrams of full-spectrum CBD.

Verdict

First, a little context: I found this delightful morsel in a small fridge at the general store in my home town in Vermont. Maybe it’s not a supplement in the traditional sense, but if I’ve learned anything while consuming all of these things, it’s that the word doesn’t have a stringent definition. The official version is “something that completes or enhances something when added to it,” and I had a hunch that white chocolate and butterscotch had a high chance of enhancing my afternoon.

Based on the 25 or so seconds that it took for me to crack through the truffle’s outer shell, releasing a wave of smooth buttery, caramel-y flavor that first contrasted then melded with the confection that encased it, and let it all dissolve into nothingness inside my mouth, I can objectively state that this particular supplement — whether it calls itself that or not — makes good on everything it promises.

Tanner Bowden

Tanner Bowden is a staff writer at Gear Patrol covering all things outdoors and fitness. He is a graduate of the National Outdoor Leadership School and a former wilderness educator. He lives in Brooklyn but will always identify as a Vermonter.

More by Tanner Bowden | Follow on Instagram · Contact via Email

Source: https://gearpatrol.com/2020/05/30/strange-supplements-tested/

The post A Totally Non-Scientific Test of 6 Non-Approved Supplements – Gear Patrol appeared first on CBD Oil Headlines.

]]>
Momentum Builds Behind the Push for Psilocybin Decriminalization – PRNewswire https://cbdoilheadlines.com/momentum-builds-behind-the-push-for-psilocybin-decriminalization-prnewswire/?utm_source=rss&utm_medium=rss&utm_campaign=momentum-builds-behind-the-push-for-psilocybin-decriminalization-prnewswire Sun, 31 May 2020 01:48:22 +0000 http://CBMieGh0dHBzOi8vd3d3LnBybmV3c3dpcmUuY29tL25ld3MtcmVsZWFzZXMvbW9tZW50dW0tYnVpbGRzLWJlaGluZC10aGUtcHVzaC1mb3ItcHNpbG9jeWJpbi1kZWNyaW1pbmFsaXphdGlvbi0zMDEwNjc1MzkuaHRtbNIBAA NEW YORK, May 29, 2020 /PRNewswire/ — Several recent developments indicate that psychedelic products for medical use are getting the attention of businesses and politicians alike. For example, earlier in April, a New York lawmaker introduced a bill to decriminalize psilocybin mushrooms by removing the main active ingredient from the […]

The post Momentum Builds Behind the Push for Psilocybin Decriminalization – PRNewswire appeared first on CBD Oil Headlines.

]]>
NEW YORK, May 29, 2020 /PRNewswire/ — Several recent developments indicate that psychedelic products for medical use are getting the attention of businesses and politicians alike. For example, earlier in April, a New York lawmaker introduced a bill to decriminalize psilocybin mushrooms by removing the main active ingredient from the state’s list of controlled substances. Psilocybin is a naturally occurring psychedelic prodrug compound produced by more than 200 species of mushrooms, collectively known as psilocybin mushrooms. In its justification, the bill indicates that many cities, including Denver, CO, Santa Cruz, CA, and Oakland, CA, have already decriminalized the use and possession of psilocybin, and New York should do the same. With the opportunity to positively affect the lives of millions suffering with mental health and addiction issues, the bill would decriminalize psilocybin and allow further research into the study of the drug and its beneficial uses for treatment. In addition, data published in the Proceedings of the National Academy of Sciences shows that, under the influence of psilocybin, the brain creates a feedback loop of neuron activity and neurotransmitter release (the chemical messengers that neurons use to communicate). According to the study, this provides an understanding of why psilocybin is showing considerable promise as a therapeutic intervention for neuropsychiatric disorders including depression, anxiety, and addiction. Numinus Wellness Inc. (TSX-V: NUMI) (OTC: LKYSD), Cronos Group Inc. (NASDAQ: CRON), Tilray, Inc. (NASDAQ: TLRY), Canopy Growth Corporation (NYSE: CGC) (TSX: WEED), Aurora Cannabis Inc. (NYSE: ACB)

The path of psychedelic products for medicinal purposes resembles the path cannabis products took towards legalization. CBD products have become more popular and well-known because of their lack of psychoactive effects many associate with cannabis. For example, in a survey conducted by HelloMD and Brightfield Group, approximately 60% out of 2,400 patients said that CBD participants used the compound to successfully treat insomnia or other sleep problems. Meanwhile, 42% percent of CBD users stopped using traditional medications and now use cannabis instead, and 80% of CBD users found CBD be very or extremely effective for treatment. Yet despite extensive research and growing popularity, the FDA has only approved one cannabis-based drug, Epidolex, which is used to treat epilepsy. Nevertheless, thousands of retailers and ecommerce platforms have already began selling CBD products after the passage of the U.S. Farm Bill in 2018. 

Numinus Wellness Inc. (TSX-V: NUMI) (OTC: LKYSD) announced breaking news yesterday regarding, “its near-term goals to advance our mission to address the universal desire to heal.

For 2020, the Company plans to upgrade its lab and processing facilities (for both cannabis and psychedelic substances), seek additional licences related to psychedelic substances and cannabis products, identify and build out a second wellness centre and develop psychedelic therapy protocols.

Numinus believes the societal costs of mental illness, addictions, trauma and unmet human potential are much too high. New approaches and new ways of thinking are required to supplement existing options, including the application of psychedelic assisted therapies when approved by regulators.

‘We are not a concept. We are a growth story,’ says Numinus CEO Payton Nyquvest. ‘That means executing on our business plan and advancing each piece of our value chain — one we have in place today.’

Numinus Bioscience, through its wholly-owned subsidiary Salvation Botanicals, has a 7,000 square foot laboratory located in Nanaimo, B.C. and is licensed by Health Canada to test, sell, distribute, and eventually conduct research on psychedelic substances, as well as test and analyze cannabis products. Numinus Wellness is dedicated to therapies that enhance and supplement existing options for people wanting lasting physical, mental and emotional health — with psychedelic treatments at its core when approved for therapeutic and research use. Numinus R&D is creating partnerships with leading research groups to advance practice and understanding in the space. Company plans for 2020 include:

  • Upgrade existing laboratory and processing facilities including systems, instruments and the building to obtain GMP compliance to facilitate R&D and clinical studies
  • Amend dealer’s license under Health Canada’s Controlled Substances Act to include import/export, packaging and R&D
  • Identify and build out a purpose-built facility to complement our existing wellness centre. Psychedelic assisted therapies will not be available at the existing centre and will only be available at our purpose-built facility through research or clinical trials once approved by regulators and governing bodies — a process Numinus is helping to support
  • Explore potential acquisition of additional existing wellness facilities in North America
  • Establish partnerships to advance Psychedelic Therapy Protocol development, under the direction of Numinus Chief Medical Officer, Dr. Evan Wood
  • Pursue American and European securities listings to provide investment opportunities for international markets and engage appropriate investor relations groups to support this process

‘We are building a solid team to deliver on our business plan,’ Nyquvest says. ‘And, revenue from our existing cannabis testing operations provides us a foundation for growth – differentiating us from others in the psychedelics space. This offering will be strengthened by a standard processing/extraction licence from Health Canada which the Company hopes to be granted in Q4 2020.’

For our latest “Buzz on the Street” Show featuring Numinus Wellness Inc. recent corporate news, please head over to: https://www.youtube.com/watch?v=WqP9NkQHfPg

Cronos Group Inc. (NASDAQ: CRON) announced last September that it had closed its previously announced acquisition of four Redwood Holding Group, LLC operating subsidiaries. The transaction provides Cronos Group with a leading U.S. hemp-based products platform, including hemp-derived cannabidiol infused skincare and other consumer products that are sold online and through retail and hospitality partner channels in the United States under the brand, Lord Jones™. Mike Gorenstein, Cronos Group’s Chairman, President and Chief Executive Officer, said, “this acquisition is one of a number of new growth opportunities that is differentiating our company and our strategic direction. We are pleased to have completed this acquisition and look forward to working closely with Rob and Cindy to further build on their record of innovation and fully capitalize on the platform they have created.”

Tilray, Inc. (NASDAQ: TLRY) announced earlier this year its entry into a strategic agreement with Canndoc Ltd., a wholly-owned subsidiary of InterCure Ltd., through its wholly-owned subsidiary Tilray Portugal Unipessoal Lda., to export a wholesale shipment of up to 2.5 tons of medical cannabis from Portugal to Israel. “The cooperation between Canndoc, an Israeli cannabis pioneer and Tilray, a global cannabis pioneer, is a significant breakthrough for both Canndoc and the entire Israeli market,” said Ehud Barak, former Israeli Prime Minister and Chairman of the Canndoc Board of Directors. “This enables the two companies to offer a broad product range for Israeli patients and patients worldwide in the near future. This is an important milestone for Canndoc’s growth strategy.”

Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) announced last month news regarding the American-made CBD brand, First & Free, a new line of CBD Creams: Everyday, Motion and Revitalize. The creams are the latest addition to First & Free’s portfolio of hemp-derived CBD isolate products including oil drops and softgel capsules, which launched exclusively in the U.S. last December. The new product line includes three distinct topical creams with CBD isolate that has been derived from 100% USA-grown hemp. Each 1.76 oz tube contains 2500 mg of CBD, making First & Free the highest strength hemp-derived CBD topical cream on the US market. (*Based on product portfolios from the top 5 CBD companies according to Brightfield Research Group 2018-19 data). According to Canopy Growth Chief Commercial Officer David Bigioni, “With our new line of topical creams, First & Free is building a portfolio to treat the everyday stressors that affect both body and mind. We’re proud to offer the highest strength topical cream on the US market – up to five times the CBD of other topicals – at a great value.”

Aurora Cannabis Inc. (NYSE: ACB) announced on February 3rd, 2020 its Aurora River production facility, located in Bradford, Ontario, has received European Union Good Manufacturing Practice certification. EU GMP certification is granted to companies whose production facilities demonstrate a high degree of quality and consistency in their manufacturing procedures and is a requirement for the export of medical cannabis products into most European markets.  “Aurora is leading the development of medical markets across Europe and around the world,” said Terry Booth, CEO of Aurora. “The EU GMP certification of our River facility further validates our strategy focused on purpose-built facilities, designed and constructed exclusively for the production of high-quality, pharmaceutical grade cannabis. I congratulate our team on successfully working with regulators and licensing bodies to ensure Aurora’s facilities and products are in accordance with local and international standards that will allow for greater access to the highest quality medical cannabis products to patients who need them.”

Subscribe Now! Watch us report LIVE https://www.youtube.com/FinancialBuzzMedia

Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz

Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz

Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/

About FinancialBuzz.com 

FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the “site”) is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. FinancialBuzz.com has not been compensated directly by any of the companies mentioned here in this editorial unless mentioned otherwise. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com does not offer any personal opinions or bias commentary as we purely incorporate public market information along with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For Numinus Wellness Inc. financial and corporate news dissemination, FinancialBuzz.com has been compensated five thousand dollars by the company. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com will always disclose any compensation in securities or cash payments for financial news PR advertising. FinancialBuzz.com does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: http://www.FinancialBuzz.com.

Media Contact:

[email protected]

+1-877-601-1879

www.FinancialBuzz.com

SOURCE FinancialBuzz.com

Source: https://www.prnewswire.com/news-releases/momentum-builds-behind-the-push-for-psilocybin-decriminalization-301067539.html

The post Momentum Builds Behind the Push for Psilocybin Decriminalization – PRNewswire appeared first on CBD Oil Headlines.

]]>